上海医药

- 601607

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
上海医药(601607) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入13,941,314.557,015,278.7526,029,508.8919,750,831.4213,259,215.73
营业收入13,941,314.557,015,278.7526,029,508.8919,750,831.4213,259,215.73
二、营业总成本13,489,016.886,789,186.9125,300,886.3719,137,981.3512,820,580.75
营业成本12,324,516.096,212,477.0122,896,694.7017,354,589.9011,553,349.21
营业税金及附加39,968.3920,854.4073,810.6454,835.7737,717.29
销售费用656,506.67329,127.731,390,219.151,047,004.88773,287.55
管理费用286,929.24139,139.67571,182.74419,311.77276,273.74
财务费用70,593.9237,442.91148,575.76115,434.7677,321.97
研发费用110,502.5750,145.19220,403.37146,804.27102,630.99
资产减值损失----------
公允价值变动收益11,428.865,225.2240,473.1423,902.3519,684.24
投资收益24,636.2816,644.24-6,812.27-8,382.44-19,899.24
其中:对联营企业和合营企业的投资收益36,561.2620,327.9012,932.878,991.90-6,541.93
汇兑收益----------
三、营业利润483,089.69241,468.23766,723.47655,595.51455,808.42
加:营业外收入1,506.261,449.924,068.972,750.801,810.56
减:营业外支出2,393.881,248.1165,362.776,446.804,239.73
其中:非流动资产处置损失----------
四、利润总额482,202.07241,670.03705,429.67651,899.52453,379.25
减:所得税费用122,465.7655,112.80188,772.65156,522.70111,679.15
五、净利润359,736.30186,557.23516,657.03495,376.82341,700.10
归属于母公司所有者的净利润294,191.14154,227.76376,799.96379,677.07260,982.18
少数股东损益65,545.1732,329.48139,857.07115,699.7680,717.92
六、每股收益
基本每股收益(元/股)0.79000.42001.02001.03000.7100
稀释每股收益(元/股)0.79000.42001.02001.03000.7100
七、其他综合收益-3,564.3946.32-12,671.99-17,096.64-12,284.93
八、综合收益总额356,171.91186,603.56503,985.04478,280.18329,415.18
归属于母公司所有者的综合收益总额290,949.88153,736.44364,323.38362,933.53248,290.46
归属于少数股东的综合收益总额65,222.0332,867.12139,661.66115,346.6581,124.72
下载全部历史数据到excel中 返回页顶